Federal regulators say shortages of Ozempic and Wegovy have been resolved, as supplies of popular diabetes and obesity ...

David Ricks said drugs like Mounjaro and Zepbound are priced to reflect the costs involved, patent expiry, and the enormous ...

Eli Lilly Chief Scientific Officer Dan Skovronsky spoke to CNBC about obesity pills and more on the future of weight loss.

Ireland's pharmaceutical industry shipped billions' worth of goods to the U.S., but face threats from Trump 2.0.

For years, conventional wisdom has been that weight loss is a matter of willpower. Those who are overweight or obese just need to try harder to eat less and exercise more. But while diet and ...

Eli Lilly’s launch of GLP-1 weight loss medication Zepbound, which it produces from a Cork site, could well explain much of the drastic €18.6 billion ($19.4 billion) increase in Irish goods ...

The company created its GLP-1 Insurance Checker specifically to help you determine your coverage on popular weight loss drugs like Ozempic, Wegovy, and Zepbound. If you're new to Ro, they'll even ...

its lack of subscription fees and its handy smartphone app with a chat feature for patients to talk to one another during their weight-loss journeys. The Zappy chat was ultimately how many ...

its lack of subscription fees and its handy smartphone app with a chat feature for patients to talk to one another during their weight-loss journeys. The issue: The Zappy chat was ultimately how ...

A telehealth company partnered with a pharmacy that lacked a required license, raising doubts about the safety and efficacy of the weight-loss ... Lilly's obesity drug Zepbound.) ...

Wegovy and Zepbound. The drugs were widely effective and soon became popular among Americans and others around the world wanting to lose weight. Ozempic has already been blamed for the demise of ...